Daniel A. Hussar

822 total citations
147 papers, 638 citations indexed

About

Daniel A. Hussar is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Molecular Biology. According to data from OpenAlex, Daniel A. Hussar has authored 147 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pediatrics, Perinatology and Child Health, 17 papers in Pharmacology and 16 papers in Molecular Biology. Recurrent topics in Daniel A. Hussar's work include Pharmaceutical studies and practices (30 papers), Pharmaceutical Economics and Policy (9 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Daniel A. Hussar is often cited by papers focused on Pharmaceutical studies and practices (30 papers), Pharmaceutical Economics and Policy (9 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Daniel A. Hussar collaborates with scholars based in United States, Netherlands and United Kingdom. Daniel A. Hussar's co-authors include William S. Bond, James T. Doluisio, Paul J. Niebergall, Edwin T. Sugita, Cheryl Abbas, Karen Suchanek Hudmon, Christine M. Fenlon, Robin L. Corelli, Elias B. Chahine and Jerry Snidow and has published in prestigious journals such as The Journal of the American Dental Association, Journal of Pharmacy and Pharmacology and The Pediatric Infectious Disease Journal.

In The Last Decade

Daniel A. Hussar

118 papers receiving 578 citations

Peers

Daniel A. Hussar

PPCH

GG

MB

FP

PHARM

Chetna Desai India

Nageeb Hassan United Arab Emirates

Dumessa Edessa Ethiopia

Lavoisier Cardozo United States

Marília Berlofa Visacri Brazil

M. A. Mangues Spain

Mikaël Daouphars France

Vincent D. Marshall United States

Sílvio Barberato-Filho Brazil

Farida Islahudin Malaysia

Chetna Desai India

Daniel A. Hussar

80 ×1.1

PPCH

68 ×0.9

GG

72 ×1.0

MB

63 ×0.9

FP

51 ×0.8

PHARM

Citations per year, relative to Daniel A. Hussar Daniel A. Hussar (= 1×) peers Chetna Desai

Countries citing papers authored by Daniel A. Hussar

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Hussar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Hussar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Hussar more than expected).

Fields of papers citing papers by Daniel A. Hussar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Hussar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Hussar. The network helps show where Daniel A. Hussar may publish in the future.

Co-authorship network of co-authors of Daniel A. Hussar

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Hussar. A scholar is included among the top collaborators of Daniel A. Hussar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Hussar. Daniel A. Hussar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hussar, Daniel A.. (2021). New Drugs 2021, Part 2. Nursing. 51(10). 18–29. 1 indexed citations

2.

Hussar, Daniel A.. (2019). New Drugs 2019, part 3. Nursing. 49(8). 24–32. 1 indexed citations

3.

Hussar, Daniel A.. (2019). New Drugs 2020, part 1. Nursing. 50(2). 31–38. 6 indexed citations

4.

Hussar, Daniel A.. (2015). 2015 new drug update. The Consultant Pharmacist. 30(4). 192–208. 2 indexed citations

5.

Hussar, Daniel A. & Cheryl Abbas. (2010). New drugs: Asenapine, iloperidone, and bepotastine besilate. Journal of the American Pharmacists Association. 50(1). 107–110. 9 indexed citations

6.

Hussar, Daniel A., et al.. (2010). New drugs: Denosumab, dienogest/estradiol valerate, and polidocanol. Journal of the American Pharmacists Association. 50(5). 658–662. 8 indexed citations

7.

Hussar, Daniel A.. (2009). New drugs: Tapentadol hydrochloride, tolvaptan, and benzyl alcohol. Journal of the American Pharmacists Association. 49(5). 704–707. 2 indexed citations

8.

Hussar, Daniel A.. (2009). New drugs: Golimumab, besifloxacin hydrochloride, and artemether/lumefantrine. Journal of the American Pharmacists Association. 49(4). 570–573. 3 indexed citations

9.

Hussar, Daniel A., et al.. (2008). New drugs: Etravirine, sinecatechins, and desvenlafaxine succinate. Journal of the American Pharmacists Association. 48(3). 428–431. 3 indexed citations

10.

Hussar, Daniel A.. (2008). New drugs: Methylnaltrexone bromide, alvimopan, and rilonacept. Journal of the American Pharmacists Association. 48(5). 688–691. 1 indexed citations

11.

Hussar, Daniel A.. (2008). <b>New Drug Update: 2007</b>. The Consultant Pharmacist. 23(4). 276–296. 1 indexed citations

12.

Hussar, Daniel A.. (2007). New drugs: Aliskiren hemifumarate, lisdexamfetamine dimesylate, and lapatinib. Journal of the American Pharmacists Association. 47(3). 425–430. 1 indexed citations

13.

Hussar, Daniel A.. (2007). New drugs: Retapamulin, bismuth subcitrate potassium, and rotigotine. Journal of the American Pharmacists Association. 47(4). 539–543. 1 indexed citations

14.

Hussar, Daniel A.. (2006). New Drugs: Ramelteon, Tipranavir, Nepafenac, and Deferasirox. Journal of the American Pharmacists Association. 46(1). 107–111.

15.

Hussar, Daniel A.. (2006). New Drugs: Rasagiline Mesylate, Conivaptan Hydrochloride, and Sunitinib Malate. Journal of the American Pharmacists Association. 46(5). 650–655. 1 indexed citations

16.

Hussar, Daniel A.. (2003). New Drugs of 2002. Journal of the American Pharmaceutical Association (1996). 43(2). 207–248. 5 indexed citations

17.

Hussar, Daniel A.. (2002). New Drugs, 2002 Part I. Nursing. 32(1). 52–59. 1 indexed citations

18.

Hussar, Daniel A.. (2001). New Drugs of 2000. Journal of the American Pharmaceutical Association (1996). 41(2). 229–272. 6 indexed citations

19.

Hussar, Daniel A.. (1999). New drugs99, part III. Nursing. 29(6). 43–48. 1 indexed citations

20.

Hussar, Daniel A.. (1991). New Drugs of 1990. American Pharmacy. 31(3). 54–79. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact